Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today
Sign in to our library of over $5 million worth of researchclose

Two Quick Steps

* Required Fields

Click Your Industry



Registered Customers

If you have an account with us, please log in.

* Required Fields



Subscribe today

We deliver Mobile Wallet Market Research and SWOT Analysis from Alternative Energy to Pharmaceuticals and Healthcare Market Research Reports to Digital Media.

Skip to Main Content »

Search Site
Researchers Currently Online:1341

Sepsis Global Clinical Trials Review, Q2, 2011

Sepsis Global Clinical Trials Review, Q2, 2011

Double click on above image to view full picture

Zoom Out
Zoom In
Additional Information
Price $1,000.00
Meta Description Sepsis Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Sepsis Global Clinical Trials
Publisher GlobalData
Date of Report Jun 15, 2011
Quick Overview
Sepsis Global Clinical Trials Review, Q2, 2011

Summary

GlobalData's clinical trial report, “Sepsis Global Clinical Trials Review, Q2, 2011" provides data on the Sepsis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Sepsis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Sepsis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Sepsis 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by Phase 18
In Progress Trials by Phase 19
Clinical Trials by Trial Status 20
Unaccomplished Trials of Sepsis 21
Subjects Recruited Over a Period of Time 25
Prominent Sponsors 26
Top Companies Participating in Sepsis Therapeutics Clinical Trials 28
Prominent Drug Comparison 30
Clinical Trial Profiles 31
Clinical Trial Overview of Top Companies 31
Eli Lilly and Company 31
Clinical Trial Overview of Eli Lilly and Company 31
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
AstraZeneca PLC 34
Clinical Trial Overview of AstraZeneca PLC 34
Eisai Inc. 35
Clinical Trial Overview of Eisai Inc. 35
Takeda Pharmaceutical Company Limited 36
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 36
Am-Pharma B.V. 37
Clinical Trial Overview of Am-Pharma B.V. 37
Agennix AG 38
Clinical Trial Overview of Agennix AG 38
Bharat Serums And Vaccines Limited 39
Clinical Trial Overview of Bharat Serums And Vaccines Limited 39
Takeda Global Research and Development Center, Inc 40
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 40
ICOS Corporation 41
Clinical Trial Overview of ICOS Corporation 41
Atox Bio Inc. 42
Clinical Trial Overview of Atox Bio Inc. 42
Artisan Pharma, Inc. 43
Clinical Trial Overview of Artisan Pharma, Inc. 43
Altor BioScience Corporation 44
Clinical Trial Overview of Altor BioScience Corporation 44
Merck & Co., Inc. 45
Clinical Trial Overview of Merck & Co., Inc. 45
Inverness Medical Canada Inc. 46
Clinical Trial Overview of Inverness Medical Canada Inc. 46
Green Cross Corporation 47
Clinical Trial Overview of Green Cross Corporation 47
Inhibitex, Inc. 48
Clinical Trial Overview of Inhibitex, Inc. 48
MicroPhage Inc. 49
Clinical Trial Overview of MicroPhage Inc. 49
Pfizer Inc. 50
Clinical Trial Overview of Pfizer Inc. 50
LEO Pharma A/S 51
Clinical Trial Overview of LEO Pharma A/S 51
Clinical Trial Overview of Top Universities / Institutes / Hospitals 52
Charite University 52
Clinical Trial Overview of Charite University 52
Duke University 53
Clinical Trial Overview of Duke University 53
The University of Texas Health Science Center at Houston 54
Clinical Trial Overview of The University of Texas Health Science Center at Houston 54
The Ohio State University 55
Clinical Trial Overview of The Ohio State University 55
Mayo Clinic 56
Clinical Trial Overview of Mayo Clinic 56
Department of Health 57
Clinical Trial Overview of Department of Health 57
Johns Hopkins University 58
Clinical Trial Overview of Johns Hopkins University 58
Assistance Publique - Hopitaux de Paris 59
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 59
Radboud University 60
Clinical Trial Overview of Radboud University 60
University Hospital Basel 61
Clinical Trial Overview of University Hospital Basel 61
Emory University 62
Clinical Trial Overview of Emory University 62
Austin Health 63
Clinical Trial Overview of Austin Health 63
Medical University of Vienna 64
Clinical Trial Overview of Medical University of Vienna 64
Tel-Aviv Sourasky Medical Center 65
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 65
Herlev Hospital 66
Clinical Trial Overview of Herlev Hospital 66
Hospital Clinic de Barcelona 67
Clinical Trial Overview of Hospital Clinic de Barcelona 67
The Medical University of Graz 68
Clinical Trial Overview of The Medical University of Graz 68
University of Athens 69
Clinical Trial Overview of University of Athens 69
The National Institute of Allergy and Infectious Diseases 70
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 70
The University of Utah 71
Clinical Trial Overview of The University of Utah 71
Appendix 72
Abbreviations 72
Definitions 72
Research Methodology 73
Secondary Research 73
About GlobalData 73
Contact Us 73
Disclaimer 74
Source 74




...